A prospective study of the rate of progr
✍
Jules L. Dienstag; Marc G. Ghany; Timothy R. Morgan; Adrian M. Di Bisceglie; Her
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 431 KB
👁 1 views
The incidence of liver disease progression among subjects with histologically advanced but compensated chronic hepatitis C is incomplete. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial was a randomized study of 3.5 years of maintenance peginterferon treatment on liver disease